ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 897,37
-0,12%
Dow Jones
44 880,26
0,37%
DAX
21 430,58
0,71%
Brent Oil
76,035
-0,31%
Bitcoin
102 863,53
0,76%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Black Diamond Therapeutics Inc (BDTX) Cours

Black Diamond Therapeutics Inc

Black Diamond Therapeutics Inc (BDTX)

NASDAQ
2,415
-0,035
( -1,43% )
Mis à jour : 19:14:38
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
2,415
Prix Achat
2,41
Prix Vente
2,42
Volume échangé
260 213
2,30 Fourchette du Jour 2,43
1,91 Plage de 52 semaines 7,66
Cap du marché
136,653M
Clôture Veille
2,45
Ouverture
2,42
Dernière Transaction
200
@
2.415
Dernière heure de transaction
19:15:11
Volume financier
US$ 614 972
VWAP
2,3633
Volume moyen (3 m)
765 165
Actions en circulation
56 585 063
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,64
Bénéfice par action (BPA)
-1,46
Chiffre d'affairess
-
Bénéfice net
-82,44M

À propos de Black Diamond Therapeutics Inc

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its d... Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.blackdiamondtherapeutics.com
Siège social
Dover, Delaware, USA
Fondé
-
Black Diamond Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker BDTX. Le dernier cours de clôture d'Black Diamond Therapeutics était de US$2,45. Au cours de la dernière année, les actions de Black Diamond Therapeutics ont été négociées dans une fourchette de prix de US$ 1,91 à US$ 7,66.

Black Diamond Therapeutics compte actuellement 56 585 063 actions en circulation. La capitalisation boursière d'Black Diamond Therapeutics est de US$138,63 million. Black Diamond Therapeutics a un ratio cours/bénéfice (ratio PE) de -1.64.

BDTX Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

16 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 Décembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Novembre 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

14 Novembre 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

08 Novembre 2024
Edgar (US Regulatory)

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, and C797S resistance mutations in September 2024...

05 Novembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

05 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

05 Novembre 2024
Edgar (US Regulatory)

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of...

01 Novembre 2024
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

24 Octobre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.2411.03448275862.1752.64062.18603722.49015633CS
40.22510.27397260272.192.671.9114581862.28532241CS
12-0.88-26.70713201823.2953.441.917651652.42116821CS
26-3.785-61.04838709686.26.751.919819923.81019505CS
52-0.465-16.14583333332.887.661.918437174.34746094CS
156-1.165-32.54189944133.587.661.187836304.67072217CS
260-30.585-92.68181818183346.251.186167178.29777687CS

BDTX - Frequently Asked Questions (FAQ)

What is the current Black Diamond Therapeutics share price?
The current share price of Black Diamond Therapeutics is US$ 2,415
How many Black Diamond Therapeutics shares are in issue?
Black Diamond Therapeutics has 56 585 063 shares in issue
What is the market cap of Black Diamond Therapeutics?
The market capitalisation of Black Diamond Therapeutics is USD 138,63M
What is the 1 year trading range for Black Diamond Therapeutics share price?
Black Diamond Therapeutics has traded in the range of US$ 1,91 to US$ 7,66 during the past year
What is the PE ratio of Black Diamond Therapeutics?
The price to earnings ratio of Black Diamond Therapeutics is -1,64
What is the reporting currency for Black Diamond Therapeutics?
Black Diamond Therapeutics reports financial results in USD
What is the latest annual profit for Black Diamond Therapeutics?
The latest annual profit of Black Diamond Therapeutics is USD -82,44M
What is the registered address of Black Diamond Therapeutics?
The registered address for Black Diamond Therapeutics is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the Black Diamond Therapeutics website address?
The website address for Black Diamond Therapeutics is www.blackdiamondtherapeutics.com
Which industry sector does Black Diamond Therapeutics operate in?
Black Diamond Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RNAZTransCode Therapeutics Inc
US$ 15,6179
(128,67%)
30,62M
SLXNSilexion Therapeutics Corporation
US$ 1,11
(91,38%)
187,6M
TOIIWOncology Institute Inc
US$ 0,0498
(66,00%)
17,57k
TRIBTrinity Biotech PLC
US$ 1,16
(52,63%)
104,06M
HEPAHepion Pharmaceuticals Inc
US$ 0,2418
(46,55%)
268,03M
LPTXLeap Therapeutics Inc
US$ 0,66805
(-70,31%)
9,5M
STSSSharps Technology Inc
US$ 0,439853
(-69,87%)
14,03M
SABSSAB Biotherapeutics Inc
US$ 2,45
(-43,81%)
1,07M
MGOLMGO Global Inc
US$ 0,1621
(-42,72%)
19,91M
TECXTectonic Therapeutic Inc
US$ 23,93
(-41,89%)
266,74k
NVDANVIDIA Corporation
US$ 126,6346
(6,94%)
370,05M
HEPAHepion Pharmaceuticals Inc
US$ 0,2416
(46,42%)
268,03M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,5294
(28,46%)
205,11M
SLXNSilexion Therapeutics Corporation
US$ 1,11
(91,38%)
187,6M
TRIBTrinity Biotech PLC
US$ 1,16
(52,63%)
104,06M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
BDTX
Black Diamond Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés